CA124570/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2008	3
2009	9
2010	11
2011	15
2012	19
2013	22
2014	24
2015	23
2016	13
2017	13
2018	12
2019	9
2020	8
2021	4
2022	1
2023	1
2024	0

1

WWP1 Gain-of-Function Inactivation of PTEN in Cancer Predisposition.

Lee YR, Yehia L, Kishikawa T, Ni Y, Leach B, Zhang J, Panch N, Liu J, Wei W, Eng C, Pandolfi PP. Lee YR, et al. N Engl J Med. 2020 May 28;382(22):2103-2116. doi: 10.1056/NEJMoa1914919. N Engl J Med. 2020. PMID: 32459922 Free PMC article.

2

Unexpected cancer-predisposition gene variants in Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome patients without underlying germline PTEN mutations.

Yehia L, Ni Y, Sesock K, Niazi F, Fletcher B, Chen HJL, LaFramboise T, Eng C. Yehia L, et al. PLoS Genet. 2018 Apr 23;14(4):e1007352. doi: 10.1371/journal.pgen.1007352. eCollection 2018 Apr. PLoS Genet. 2018. PMID: 29684080 Free PMC article.

3

A clinical scoring system for selection of patients for PTEN mutation testing is proposed on the basis of a prospective study of 3042 probands.

Tan MH, Mester J, Peterson C, Yang Y, Chen JL, Rybicki LA, Milas K, Pederson H, Remzi B, Orloff MS, Eng C. Tan MH, et al. Am J Hum Genet. 2011 Jan 7;88(1):42-56. doi: 10.1016/j.ajhg.2010.11.013. Epub 2010 Dec 30. Am J Hum Genet. 2011. PMID: 21194675 Free PMC article.

4

PTEN-opathies: from biological insights to evidence-based precision medicine.

Yehia L, Ngeow J, Eng C. Yehia L, et al. J Clin Invest. 2019 Feb 1;129(2):452-464. doi: 10.1172/JCI121277. Epub 2019 Jan 7. J Clin Invest. 2019. PMID: 30614812 Free PMC article. Review.

5

When overgrowth bumps into cancer: the PTEN-opathies.

Mester J, Eng C. Mester J, et al. Am J Med Genet C Semin Med Genet. 2013 May;163C(2):114-21. doi: 10.1002/ajmg.c.31364. Am J Med Genet C Semin Med Genet. 2013. PMID: 23613428 Review.

6

Thyroid nodules and cancer management guidelines: comparisons and controversies.

Nabhan F, Ringel MD. Nabhan F, et al. Endocr Relat Cancer. 2017 Feb;24(2):R13-R26. doi: 10.1530/ERC-16-0432. Epub 2016 Dec 13. Endocr Relat Cancer. 2017. PMID: 27965276 Free PMC article. Review.

7

MicroRNA-related sequence variations in human cancers.

Wojcicka A, de la Chapelle A, Jazdzewski K. Wojcicka A, et al. Hum Genet. 2014 Apr;133(4):463-9. doi: 10.1007/s00439-013-1397-x. Epub 2013 Nov 19. Hum Genet. 2014. PMID: 24241281 Free PMC article. Review.

8

PTEN hamartoma tumor syndrome: clinical risk assessment and management protocol.

Ngeow J, Eng C. Ngeow J, et al. Methods. 2015 May;77-78:11-9. doi: 10.1016/j.ymeth.2014.10.011. Epub 2014 Oct 22. Methods. 2015. PMID: 25461771 Review.

9

MicroRNAs in thyroid cancer.

de la Chapelle A, Jazdzewski K. de la Chapelle A, et al. J Clin Endocrinol Metab. 2011 Nov;96(11):3326-36. doi: 10.1210/jc.2011-1004. Epub 2011 Aug 24. J Clin Endocrinol Metab. 2011. PMID: 21865360 Free PMC article. Review.

10

Mouse models of thyroid cancer: A 2015 update.

Kirschner LS, Qamri Z, Kari S, Ashtekar A. Kirschner LS, et al. Mol Cell Endocrinol. 2016 Feb 5;421:18-27. doi: 10.1016/j.mce.2015.06.029. Epub 2015 Jun 27. Mol Cell Endocrinol. 2016. PMID: 26123589 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

163 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

163 results

Results by year